Assistant Commissioner and Deputy Director, OIP, OC, FDA
Since September 2012, she has served as Assistant Commissioner and Deputy Director of the FDA’s Office of International Programs (OIP). OIP leads FDA’s international activities and oversees the operation of FDA’s eleven regional and country offices. Prior to this position...
Read More →
Deputy Director, Division of New Drug Bioequivalence, OSIS, OTS, CDER, FDA
Arindam received his M.S. in Biophysics and Molecular Biology from the University of Calcutta (1994) and Ph.D in Molecular Biology from Jadavpur University, Kolkata. After finishing his Ph.D., he was a postdoctoral researcher at UVA and NIH (1999-2008). He joined CDER as a Pharma...
Read More →
Director, Office of Study Integrity and Surveillance, OTS, CDER, FDA
Sean serves as the Director of the Office of Study Integrity and Surveillance, CDER/FDA. He oversees the bioavailability/bioequivalence (BA/BE) and GLP inspection programs that inspect and review conduct of regulated pharmaceutical premarket bioanalytical and non-clinical researc...
Read More →
Country Director, India Office, Office of International Programs, OC, FDA
Dr. Mathew T. Thomas serves as the Acting Director for the FDA India Office from February 23, 2015. Prior to this posting Mathew was the Director of the Division of Enforcement and Postmarket Safety (DEPS), in CDER’s Office of Scientific Investigations (OSI) within the Office o...
Read More →
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
